// App-Quantinova.ai

: Clinical factors associated with baseline blood eosinophils among patients with asthma or COPD: NOVELTY study

Researchers

Presenter

  • Hana Müllerová

Principal Investigators

  • Donna K Finch

  • Alvar Agustí

  • Marianna Alacqua

  • Gary P Anderson

  • Richard Beasley

  • Laura Belton

  • Alex De Giorgio-Miller

  • J Mark Fitzgerald

  • Rod Hughes

  • Ian D Pavord

  • David Price

  • Eleni Rapsomaniki

  • Mohsen Sadatsafavi

  • Jørgen Vestbo

  • Elisabeth H Bel

Medical Centers

  • Astra Zeneca, Cambridge, United Kingdom

  • Biopharma R&D, AstraZeneca, Cambridge, United Kingdom

  • Respiratory Institute, Hospital Clinic, University of Barcelona, IDIBAPS, CIBER, Barcelona, Spain,

  • Lung Health Research Centre, Department of Pharmacology and Therapeutics, University of Melbourne, Victoria, Australia

  • Medical Research Institute of New Zealand (MRINZ), Wellington, New Zealand

  • Centre for Heart and Lung Health, The Lung Centre Vancouver General Hospital, UBC Institute for Heart and Lung Health, Vancouver, BC, Canada,

  • Respiratory Medicine Unit and Oxford Respiratory NIHR BRC, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

  • Observational and Pragmatic Research Institute, Singapore and Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom

  • Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

  • University of Manchester, Manchester University Foundation Trust NHS Hospital, Manchester, United Kingdom,

  • Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Locations

  • United Kingdom

  • Spain

  • Australia

  • New Zealand

  • Canada

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

Disease

  • Asthma

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • NCT02760329

Sponsors

  • N/A

Result

  • N/A